大阪大学 大学院医学系研究科 放射線統合医学講座 核医学 ／ 大阪大学医学部附属病院 核医学診療科

教室紹介

業績

Results
  1. トップページ
  2. 教室紹介
  3. 業績
  4. 2022年

2022年

  1. Fujimori T, Suzuki Y, Takenaka S, Kita K, Kanie Y, Kaito T, Ukon Y, Watabe T, Nakajima N, Kido S, Okada S. Development of artificial intelligence for automated measurement of cervical lordosis on lateral radiographs. Sci Rep. 2022 Sep 21;12(1):15732.
  2. Fukui H, Onishi H, Nakamoto A, Tsuboyama T, Ota T, Yano K, Enchi Y, Yamada D, Takeda Y, Kobayashi S, Fukuda Y, Eguchi H, Matsui T, Tatsumi M, Tomiyama N. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer. Eur J Radiol. 2022 Sep 11;156:110522.
  3. Fukui H, Onishi H, Nakamoto A, Wakayama T, Ota T, Tsuboyama T, Yano K, Tarewaki H, Koyama Y, Tatsumi M, Tomiyama N. Impact of adaptive image receive coil technology for liver MR imaging at 3.0 Tesla: Intraindividual comparison with use of conventional coil. Eur J Radiol. 2022 May;150:110271.
  4. Hatazawa J. The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update. Semin Nucl Med. 2022 Sep;52(5):619-627.
  5. Hertz B, Watabe T, Baum RP. Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranostics. Ann Nucl Med. 2022 Nov 8.
  6. Higashino M, Aihara T, Ozaki A, Hu N, Isohashi K, Ono K, Nihei K, Kurisu Y, Kawata R. Successful salvage surgery of the residual tumor after boron neutron capture therapy (BNCT): A case report. Appl Radiat Isot. 2022 Nov;189:110420.
  7. Hiroyama S, Matsunaga K, Ito M, Iimori H, Tajiri M, Nakano Y, Shimosegawa E, Abe K. Usefulness of 18 F-FPP-RGD 2  PET in pathophysiological evaluation of lung fibrosis using a bleomycin-induced rat model. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4358-4368.
  8. Huang X, Kaneda-Nakashima K, Kadonaga Y, Kabayama K, Shimoyama A, Ooe K, Kato H, Toyoshima A, Shinohara A, Haba H, Wang Y, Fukase K. Astatine-211-Labeled GoldNanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.Pharmaceutics. 2022 Dec 2;14(12):2705.
  9. Ionescu TM, Amend M, Watabe T, Hatazawa J, Maurer A, Reischl G, Pichler BJ, Wehrl HF, Herfert K. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4- Methylenedioxymethamphetamine. J Nucl Med. 2022 Sep 29
  10. Isohashi K, Kanai Y, Aihara T, Hu N, Fukushima K, Baba I, Hirokawa F, Kakino R, Komori T, Nihei K, Hatazawa J, Ono K. Exploration of the threshold SUV for diagnosis of malignancy using  18 F- FBPA PET/CT. Eur J Hybrid Imaging. 2022 Dec 5;6(1):35.
  11. Kagitani-Shimono K, Kato H, Soeda F, Iwatani Y, Mukai M, Ogawa K, Tominaga K, Nabatame S, Taniike M. Extension of microglial activation is associated with epilepsy and cognitive dysfunction in Tuberous sclerosis complex: A TSPO-PET study. Neuroimage Clin. 2022 Dec 12;37:103288.
  12. Kakino R, Hu N, Isohashi K, Aihara T, Nihei K, Ono K. Comprehensive evaluation of dosimetric impact against position errors in accelerator-based BNCT under different treatment parameter settings. Med Phys. 2022 Aug;49(8):4944-4954.
  13. Kaneda-Nakashima K, Shirakami Y, Watabe T, Ooe K, Yoshimura T, Toyoshima A, Wang Y, Haba H, Fukase K. Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter. Int J Mol Sci. 2022 Dec 7;23(24):15509.
  14. Kanemoto H, Satake Y, Suehiro T, Taomoto D, Koizumi F, Sato S, Wada T, Matsunaga K, Shimosegawa E, Hashimoto M, Yoshiyama K, Ikeda M. Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study. Alzheimers Res Ther. 2022 Sep 22;14(1):137.
  15. Kanou T, Funaki S, Minami M, Ose N, Kimura T, Fukui E, Watabe T, Shintani Y. Usefulness of positron-emission tomography for predicting the World Health Organization grade of thymic epithelial tumors. Thorac Cancer. 2022.
  16. Kato H, Nakagawara J, Hachisuka K, Hatazawa J, Ikoma K, Suehiro E, Iida H, Ogasawara K, Iizuka O, Ishiai S, Ichikawa T, Nariai T, Okazaki T, Shiga T, Mori E. Impaired neuronal integrity in traumatic brain injury detected by 123 I-iomazenil single photon emission computed tomography and MRI. J Cereb Blood Flow Metab. 2022 Dec;42(12):2245-2254.
  17. Kitajima K, Watabe T, Nakajo M, Ishibashi M, Daisaki H, Soeda F, Tanemura A, Kanekura T, Yamazaki N, Ito K. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using 18 F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST. Jpn J Radiol. 2022;40(1):75-85.
  18. Kubo M, Kobayashi S, Gotoh K, Takayama H, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Noda T, Kato H, Shimosegawa E, Doki Y, Eguchi H. Preoperative FDG-Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers. Ann Surg Oncol. 2022 Feb;29(2):935- 944.
  19. Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Naka S, Ooe K, Toyoshima A, Nagata K, Haberkorn U, Kratochwil C, Shinohara A, Hatazawa J, Giesel F. Fibroblast activation protein targeted therapy using [177 Lu]FAPI-46 compared with [ 225 Ac]FAPI-46 in a pancreatic cancer model. Eur J Nucl Med Mol Imaging. 2022;49(3):871-880.
  20. Matsuda H, Okita K, Motoi Y, Mizuno T, Ikeda M, Sanjo N, Murakami K, Kambe T, Takayama T, Yamada K, Suehiro T, Matsunaga K, Yokota T, Tateishi U, Shigemoto Y, Kimura Y, Chiba E, Kawashima T, Tomo Y, Tachimori H, Kimura Y, Sato N. Clinical impact of amyloid PET using 18 F- florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study. Ann Nucl Med. 2022 Dec;36(12):1039-1049.
  21. Miyagawa S, Kainuma S, Kawamura T, Suzuki K, Ito Y, Iseoka H, Ito E, Takeda M, Sasai M, Mochizuki-Oda N, Shimamoto T, Nitta Y, Dohi H, Watabe T, Sakata Y, Toda K, Sawa Y. Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy. Front Cardiovasc Med. 2022 Aug 16;9:950829.
  22. Miyazaki T, Takayama Y, Iwasaki M, Hatano M, Nakajima W, Ikegaya N, YamamotoT, Tsuchimoto S, Kato H, Takahashi T. Epileptic discharges initiate from brainareas with elevated accumulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Brain Commun. 2022 Feb 7;4(2):fcac023.
  23. Mori S, Kato T, Watabe T, Hatano K, Abe T, Fukuhara S, Kiuchi H, Imamura R, Uemura M, Nonomura N. Oligometastatic Lymph Node Recurrence Detected Using 18 F-PSMA-1007 PET/CT in a Patient With Castration-resistant Prostate Cancer After Radiation Therapy. Cancer Diagn Progn. 2022 Sep 3;2(5):598-602.
  24. Naeimi M, Choyke PL, Dendl K, Mori Y, Staudinger F, Watabe T, Koerber SA, Röhrich M, Debus J, Kratochwil C, Haberkorn UA, Giesel FL. 3-time-point PET-analysis of FAPI-46 in a variety of cancers. J Nucl Med. 2022 Nov 10.
  25. Naka S, Watanabe T, Kanai Y, Watabe T, Tatsumi M, Kato H, Shimosegawa E, Hatazawa J. Improved Stability and Practicality for Synthesis of 4-Borono-2-[ 18 F]fluoro-l-phenylalanine by Combination of [ 18 O]O2 Single-Use and [ 18 F]CH3COOF Labeling Agents. Nucl Med Mol Imaging. 2022;56(2):86-95.
  26. Omata A, Masubuchi M, Koshikawa N, Kataoka J, Kato H, Toyoshima A, Teramoto T, Ooe K, Liu Y, Matsunaga K, Kamiya T, Watabe T, Shimosegawa E, Hatazawa J. Multi-modal 3D imaging of radionuclides using multiple hybrid Compton cameras. Sci Rep. 2022;12(1):2546.
  27. Sugisawa E, Kondo T, Kumagai Y, Kato H, Takayama Y, Isohashi K, Shimosegawa E, Takemura N, Hayashi Y, Sasaki T, Martino MM, Tominaga M, Maruyama K. Nociceptor-derived Reg3γ prevents endotoxic death by targeting kynurenine pathway in microglia. Cell Rep. 2022 Mar 8;38(10):110462.
  28. Suzuki K, Iwai H, Utsunomiya K, Kono Y, Watabe T, Kobayashi Y, Bui DV, Sawada S, Yun Y, Mitani A, Fukui K, Sakai H, Chu HH, Linh NM, Tanigawa N, Kanda A. Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model. Int J Mol Sci. 2022 Aug 30;23(17):9872.
  29. Takahashi H, Kashiwagi N, Arisawa A, Matsuo C, Kato H, Adachi H, Kajiyama Y, Mochizuki H, Tomiyama N. Imaging of the nigrostriatal system for evaluating the preclinical phase of Parkinson's disease development: the utility of neuromelanin, diffusion MRI, and DAT-SPECT. Br J Radiol. 2022 Feb 1;95(1130):20210837.
  30. Tanaka H, Suzuki M, Takemoto N, Fukusumi T, Eguchi H, Takai E, Kanai H,Tatsumi M, Horie M, Takenaka Y, Yachida S, Inohara H. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary. Int J Cancer. 2022 Jan1;150(1):174-186.
  31. Tatsumi M, Soeda F, Naka S, Kurimoto K, Ooe K, Fukui H, Katayama D, Watabe T, Kato H, Tomiyama N. Advantages of FBPA PET in evaluating early response of anti- PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET.FrontOncol. 2022 Dec 22;12:1026608.
  32. Tsuboyama T, Sato K, Ota T, Fukui H, Onishi H, Nakamoto A, Tatsumi M, Tomiyama N. MRI of Borderline Epithelial Ovarian Tumors: Pathologic Correlation and Diagnostic Challenges. Radiographics. 2022 Nov-Dec;42(7):2095-2111.
  33. Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, Cardinale J, Giesel FL, Tomiyama N, Fukase K. Targeted α-therapy using astatine ( 211 At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound. Eur J Nucl Med Mol Imaging. 2022 Nov 8.
  34. Watabe T. Response to the letter to the editor. Ann Nucl Med. 2022 Sep;36(9):844.
  35. Watabe T, Liu Y, Kaneda-Nakashima K, Sato T, Shirakami Y, Ooe K, Toyoshima A, Shimosegawa E, Wang Y, Haba H, Nakano T, Shinohara A, Hatazawa J. Comparison of the Therapeutic Effects of [ 211 At]NaAt and [ 131 I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model. Int J Mol Sci. 2022 Aug 21;23(16):9434.
  36. Watanabe M, Kato H, Katayama D, Soeda F, Matsunaga K, Watabe T, Tatsumi M, Shimosegawa E, Tomiyama N. Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose- positron emission tomography to differentiate between benign and malignant lesions. Ann Nucl Med. 2022 Nov;36(11):951-963.
  37. Yamamichi G, Kato T, Yumiba S, Tomiyama E, Koh Y, Nakano K, Matsushita M, Hayashi Y, Ishizuya Y, Watabe T, Hatano K, Kawashima A, Ujike T, Ono Y, Takada T, Takada S, Imamura R, Nonomura N, Uemura M. Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi- institutional study. Int J Urol. 2022 Oct 28.
  38. Yamamoto S, Sanada T, Sakai M, Arisawa A, Kagawa N, Shimosegawa E, Nakanishi K, Kanemura Y, Kinoshita M, Kishima H. Prediction and Visualization of Non-Enhancing Tumor in Glioblastoma via T1w/T2w-Ratio Map. Brain Sci. 2022 Jan 12;12(1):99.
  39. Yano K, Onishi H, Tsuboyama T, Nakamoto A, Ota T, Fukui H, Tatsumi M, Tanigaki T, Gotoh K, Kobayashi S, Honma K, Eguchi H, Tomiyama N. Noninvasive Liver Fibrosis Staging: Comparison of MR Elastography with Extracellular Volume Fraction Analysis Using Contrast-Enhanced CT. J Clin Med. 2022 Sep 25;11(19):5653.
  40. Yonekura Y, Toki H, Watabe T, Kaneda-Nakashima K, Shirakami Y, Ooe K, Toyoshima A, Nakajima H, Tomiyama N, Bando M. Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with  211 At Using Implanted Mouse Tumor. Int J Mol Sci. 2022 Dec 15;23(24):15966.